Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have earned a consensus rating of “Hold” from the sixteen research firms that are presently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $26.0385.

A number of brokerages have recently commented on ACHC. Royal Bank Of Canada boosted their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Cantor Fitzgerald boosted their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Jefferies Financial Group restated a “hold” rating and issued a $24.50 price target on shares of Acadia Healthcare in a report on Monday, April 20th. UBS Group boosted their price target on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Finally, Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target on the stock in a report on Monday, May 4th.

Institutional Trading of Acadia Healthcare

Institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its holdings in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Wells Fargo & Company MN raised its holdings in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares in the last quarter. Bayforest Capital Ltd bought a new stake in Acadia Healthcare during the fourth quarter worth about $52,000. Hantz Financial Services Inc. raised its holdings in Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after acquiring an additional 2,698 shares in the last quarter.

Acadia Healthcare Stock Performance

ACHC stock opened at $25.81 on Monday. The business’s 50-day moving average price is $25.28 and its two-hundred day moving average price is $19.24. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a market cap of $2.37 billion, a PE ratio of -2.11, a P/E/G ratio of 8.68 and a beta of 0.73. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $30.20.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s revenue for the quarter was up 7.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts forecast that Acadia Healthcare will post 1.49 earnings per share for the current year.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Zacks Research raised several forward EPS estimates for Acadia Healthcare, including Q1 2027 to $0.26, Q2 2027 to $0.45, Q3 2027 to $0.54, Q4 2027 to $0.38, FY2027 to $1.63, and FY2028 to $1.76, signaling better earnings visibility ahead.
• Positive Sentiment: A separate report said Acadia Healthcare’s price target was increased by 18.24% to $28.82, which suggests analysts see more upside than before. Article Title
• Neutral Sentiment: Zacks Research kept its overall rating at Hold, so while estimates improved, the firm is not yet calling the stock a strong buy.
• Negative Sentiment: Not all revisions were positive: Zacks lowered FY2026 EPS to $1.46 from $1.48 and cut Q2 2026 EPS to $0.35 from $0.49, which may temper near-term enthusiasm.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.